NASDAQ:TNDM | Free Cash Flow | TANDEM DIABETES CARE INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$11.05M$6.27M$4.79M
2025-12-31$9.79M$6.69M$3.1M
2025-03-31-$18.28M$2.97M-$21.24M
2024-12-31$10.72M$3.07M$7.65M1012.98%
2024-03-31-$8M$4.46M-$12.45M
2023-12-31-$7.22M$5.2M-$12.42M
2023-03-31-$18.33M$8.83M-$27.15M
2022-12-31$5.82M$5.63M$193,000.00
2022-03-31$13.8M$2.64M$11.16M
2021-12-31$19.64M$5.75M$13.89M128.51%
2021-03-31$28.69M$3.52M$25.16M
2020-12-31$15.24M$4.1M$11.14M65.54%
2020-03-31-$20.63M$6.77M-$27.4M
2019-12-31$19.44M$6.75M$12.69M478.66%
2019-03-31-$4.12M$1.41M-$5.53M
2018-12-31$14.13M$888,000.00$13.25M359.14%
2018-03-31-$12.27M$514,000.00-$12.79M
2017-12-31-$11.64M$1.42M-$13.06M
2017-03-31-$20.81M$2.64M-$23.46M
2016-12-31-$13.58M$2.74M-$16.33M
2016-03-31-$15.95M$1.95M-$17.89M
2015-12-31-$10.25M$1.67M-$11.92M
2015-03-31-$15.42M$600,000.00-$16.02M
2014-12-31-$13.54M$746,000.00-$14.28M
2014-03-31-$16.96M$1.62M-$18.58M
2013-12-31-$12.83M$1.48M-$14.31M
2013-03-31-$8.81M$901,111.00-$9.71M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.72M$19.95M-$29.67M
2024-12-31$24.23M$19.23M$4.99M
2023-12-31-$31.81M$26.8M-$58.61M
2022-12-31$50.46M$34.1M$16.37M
2021-12-31$111.36M$14.18M$97.18M624.30%
2020-12-31$24.67M$27.41M-$2.74M
2019-12-31$41.91M$19.54M$22.37M
2018-12-31-$8.32M$2.99M-$11.31M
2017-12-31-$66.14M$5.72M-$71.85M
2016-12-31-$61.17M$8.93M-$70.1M
2015-12-31-$58.76M$5.76M-$64.53M
2014-12-31-$61.38M$4.41M-$65.78M
2013-12-31-$47.76M$4.01M-$51.77M
2012-12-31-$33.47M$4.53M-$38M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.